logo
Some European companies question US expansion amid tariff chaos

Some European companies question US expansion amid tariff chaos

Reuters25-04-2025

MILAN/FRANKFURT/BERLIN, April 25 (Reuters) - U.S. President Donald Trump's erratic approach to tariffs is causing some smaller European companies to question the benefits of expanding in the U.S. market - a sign of how tough it has become to navigate trade in the world's top economy.
By putting levies on everything from steel and cognac to cars and sandals, Trump aims to prompt foreign firms to move investment to the United States, building new factories and creating thousands of American jobs.
While major corporates from the auto and pharma sectors, have rushed to announce expansions or say they are considering them, the stream of announcements, roll-backs and exemptions has left some smaller firms warier of committing.
Italy's EuroGroup Laminations (EGLA.MI), opens new tab currently pays no tariffs on the rotors and stators it supplies to U.S. automotive customers, including Ford (F.N), opens new tab and GM (GM.N), opens new tab, from its plant in Mexico as they comply with existing import rules.
But even if it had to, moving production to the U.S. would expose it to tariffs in place on the special type of steel the company uses in its automotive parts, CEO Marco Arduini told Reuters.
"Skipping potential U.S. tariffs ... would not necessarily mean it can compensate for extra costs and low availability of steel," he said, adding that U.S. labour costs, which are up to six times higher than in Mexico, were also an issue.
German fan and motor maker ebm-papst has put on hold plans to build a third U.S. factory or expand one of its existing U.S. sites due to current developments, including the risk that the tariffs will trigger a U.S. recession.
"If there is an economic downturn in the U.S., demand may develop differently as a result," CEO Klaus Geissdoerfer said.
Small- and medium-sized enterprises (SMEs) are the backbone of many economies, including Italy and Germany, both European Union members and major exporters to the United States.
Because they have smaller financial buffers than blue-chip peers, they may react to fresh trade risks more quickly than bigger companies.
"Contrary to Donald Trump's hopes, his protectionism will not lead to more German companies moving to the U.S. and creating jobs there," said Marc Tenbieg, head of the DMB association that represents Germany's SMEs.
DMB in separate comments said a handful of SMEs, which declined to be named due to the sensitivity of the matter, are also currently reviewing their U.S. businesses as a result of Trump's policies.
Some member firms of German engineering association VDMA are delaying purchases, Andrew Adair, the group's trade policy advisor for North America, said following a trip to the United States earlier this month.
"Industry appears to be pressing the pause button at the moment," he said.
After weeks of threats, Trump announced on April 2 a series of broad tariffs on goods imported to the United States from most other countries. They included a 20% tariff on EU imports that was later lowered to 10% under what he called a 90-day pause following a rout in U.S. assets.
Trump's declarations that other countries have been "screwing" the U.S. for years - reflecting his ire at U.S. trade deficits, including one of $235.6 billion with the 27-nation EU - have also raised the political and diplomatic temperature.
Germany's LAPP, which makes everything from cables and wires to robotics for factories, is nevertheless sticking with plans to double production capacity at its New Jersey site in 2025.
"As a family business, we plan for the long term, not for election periods," CEO Matthias Lapp said.
One major uncertainty is what tariffs will do to demand and inflation within the United States.
RBC Capital reckons that 10% of U.S. consumption is based on imports and that it will therefore be "relatively difficult for consumers to substitute away from imported goods".
But consultancy AlixPartners reckons average U.S. household discretionary spending will fall by more than 10% to $27,000 in a post-tariff world, and recommends that companies adopt a "pause & monitor" approach.
In each of the last three years, the EU on average exported more than 500 billion euros of goods to the U.S., mostly pharmaceuticals, vehicles and machinery, Eurostat data shows.
Trump has taken aim primarily at the bloc's makers of steel, autos and car parts.
While the U.S. remains the EU's biggest trading partner, the tariffs have triggered some political pushback against taking on greater exposure, with French President Emmanuel Macron asking European firms to suspend planned investment for now.
Industry groups are urging European companies to focus instead on other foreign markets such as India, Latin America and Southeast Asia.
"We have seen that the situation can change quickly overnight," said Sebastian Zank, head of corporates ratings production at credit ratings agency Scope.
"Everyone will keep their feet still until a picture emerges that can be described as sustainable."
($1 = 0.8723 euros)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Reckitt eyes new options to advance Air Wick unit sale, sources say
Reckitt eyes new options to advance Air Wick unit sale, sources say

Reuters

time13 minutes ago

  • Reuters

Reckitt eyes new options to advance Air Wick unit sale, sources say

LONDON, June 3 (Reuters) - Britain's Reckitt (RKT.L), opens new tab is considering new options to advance a sale of its Essential Home business, home to Air Wick fresheners and Cillit Bang cleaners, after bids came in below expectations, two people with knowledge of the process said. The company still plans to pursue a sale, the people said, who spoke on condition of anonymity because the talks are private. Private equity firm Advent remains in talks for the assets, one of the people and a third person said. Reckitt, which also makes Mucinex cold medication and Durex condoms, said in July it was looking to offload a portfolio of homecare brands by the end of 2025. The proposed sale comes at a challenging time for businesses with factories around the world as they navigate U.S. President Donald Trump's tariffs, which are roiling supply chains, boosting costs and dampening shopper sentiment. Reckitt could keep a stake in the business or structure a sale another way to bridge a gap in valuations, one of the people said, adding that some of the bids came in below its hopes of over 4 billion pounds ($5.4 billion). Reuters could not determine if other bidders remained in the process. Reckitt and Advent declined to comment. Bankers and CEOs have hit the brakes on mergers and acquisitions since Trump launched his trade war, with fewer deals getting signed than during the bleakest days of the COVID-19 pandemic and the 2008-2009 global financial crisis. Reckitt said in April that it was "continuing to progress" the sale of the Essential Home business but that market conditions might affect the time frame. Consumer staples companies are considered relatively resilient to economic downturns, but big brands like Reckitt, P&G (PG.N), opens new tab and Unilever (ULVR.L), opens new tab increasingly face competition from cheaper private label brands that gained popularity during the pandemic. Reckitt's Essential Home business has struggled for several quarters, with sales falling 7% in the first quarter of this year to 482 million pounds, about 13% of total revenue for the quarter. Reckitt has been undergoing a turnaround under CEO Kris Licht, who has sought to reassure shareholders concerned about the strength of the company's brands in North America and Europe, where consumer confidence has been dwindling. ($1 = 0.7397 pounds)

US job openings rose in April, signaling resilience in the American labor market
US job openings rose in April, signaling resilience in the American labor market

The Independent

time19 minutes ago

  • The Independent

US job openings rose in April, signaling resilience in the American labor market

U.S. job openings rose unexpectedly in April, showing that the labor market remains resilient in the face of uncertainty arising from President Donald Trump's trade wars. The Labor Department reported Tuesday that employers posted 7.4 million job vacancies in April, up from 7.2 million in March. Economists had expected openings to drift down to 7.1 million. But the number of Americans quitting their jobs— a sign of confidence in their prospects — fell, and layoffs ticked higher. And in another sign the job market has cooled from the hiring boom of 2021-2023, the Labor Department reported one job every unemployed person. As recently as December 2022, there were two vacancies for every jobless American. Openings remain high by historical standards but have dropped sharply since peaking at 12.1 million in March 2022, when the economy was still roaring back COVID-19 lockdowns. The Labor Department's Job Openings and Labor Turnover Summary showed little evidence of cuts to the federal workforce by billionaire Elon Musk's Department of Government Efficiency. Openings for federal jobs rose to 134,000 in April from 121,000 in March. And federal layoffs fell to 4,000 from 8,000 in March and 19,000 in February. Although it has decelerated, the American job market has remained resilient in the face of high interest rates engineered by the Federal Reserve in 2022 and 2023 to fight a resurgence of inflation. The economic outlook is uncertain, largely because of Trump's economic policies — huge taxes on imports, purges of federal workers and the deportation of immigrants working in the United States illegally. Carl Weinberg, chief economist at High Frequency Economics, said the JOLTS report shows that companies are waiting to see how Trump's policies play out. 'Once companies are more certain that bad times are coming, they will start to shed workers,' he wrote in a commentary. 'However, the economy is still near full employment. We suspect companies are still hoarding workers until they are very, very sure about an economic downturn.″ The Labor Department is expected to report Friday that employers added 130,000 jobs last month, down from 177,000 in April. The unemployment rate is expected to stay at a low 4.2%, according to a survey of forecasters by the data firm FactSet.

What is Operation Stork Speed? RFK Jr's plan to take on the baby formula industry
What is Operation Stork Speed? RFK Jr's plan to take on the baby formula industry

The Independent

time24 minutes ago

  • The Independent

What is Operation Stork Speed? RFK Jr's plan to take on the baby formula industry

Federal health officials are set to overhaul the U.S. food supply, starting with a fresh examination of i nfant formula. Health Secretary Robert F. Kennedy Jr. has instructed the Food and Drug Administration (FDA) to conduct a thorough review of the nutrients and ingredients found in infant formula, a staple for millions of American babies. This initiative, named "Operation Stork Speed," marks the first comprehensive evaluation of these ingredients since 1998. Kennedy stated, "The FDA will use all resources and authorities at its disposal to make sure infant formula products are safe and wholesome for the families and children who rely on them." According to the Centers for Disease Control and Prevention, approximately three-quarters of infants in the U.S. consume formula within their first six months, with about 40% relying on it as their sole source of nutrition. Formula has been widely used in the U.S. for roughly six decades, feeding generations of infants who have flourished, said Dr. Steven Abrams, a University of Texas infant nutrition expert. The broader scientific community has been calling for a reevaluation of infant formula for years and is 'fully supportive of this idea of a comprehensive look,' he said. Current formula products in the U.S. continue to be safe and nourishing, he said. 'But there's been a lot of science and we want the FDA rules to align with the most recent science from around the world,' he said. Here's what you need to know about Operation Stork Speed: What is infant formula and why do so many babies consume it? Infant formula is a manufactured product, usually made from cow's milk or soy, that is intended to mimic human breast milk for kids up age 12 months. It may be the sole source of nutrition or supplement breastfeeding. FDA regulations require that infant formulas contain 30 specific nutrients, with minimum levels for all and maximum levels for 10 of them. The ingredients vary, but all formulas must have a balance of calories from protein, carbohydrates and fat that mirrors what's found in human milk. Federal guidelines recommend that babies be exclusively breastfed for the first six months of life and that parents continue breastfeeding for the first year or more while adding new foods to the child's diet. Parents use formula when a mother cannot or chooses not to breastfeed for a wide range of reasons, including medical conditions, work conflicts, to allow other family members to help with feedings and other situations. Why is the government reviewing baby formula now? Kennedy announced the review of infant formula in March as part of his 'Make America Healthy Again' agenda for the U.S. food supply. The FDA's review will include increased testing for heavy metals and other contaminants as well as a review of nutrients, the agencies said. U.S. health officials will hold a two-hour roundtable discussion of infant formula on Wednesday. What issues will that cover? The FDA is asking for new scientific data and information about whether required ingredients in infant formula should be added, removed or changed. The deadline for comments is Sept. 11. Scientists say a review is long overdue regarding the most recent data on the composition of human milk and how babies digest and absorb nutrients in breastmilk and formula. In addition, they want the FDA to consider how U.S. formulas compare with those made elsewhere, said Bridget Young, who studies infant nutrition at the University of Rochester. 'How do our regulations differ?' she said. 'Maybe it's time for them to relook at their regulations and consider potential international harmonization.' More international alignment might have eased the U.S. infant formula crisis in 2022, when contamination shut down an Abbott factory, leading to monthslong shortages for American parents, Young said. What about specific ingredients? In recent years, some parents have sought out infant formula made in Europe with the belief that products made overseas are healthier options, experts said. Formula regulations in the U.S. and Europe, including requirements for nutrients and testing, differ somewhat, but are generally similar, Abrams said. 'The differences between the U.S. and Europe should not be considered as 'higher' or 'better' or 'greater' in one vs. the other,' he said. Still, iron, for instance, is included at higher levels in U.S. formulas than in those in Europe — and Abrams suggested that U.S. officials may consider lowering iron targets. Other components have been added to formula in recent years. They include docosahexaenoic acid, or DHA, an essential omega-3 fatty acid, and human milk oligosaccharides, complex sugars that are found breast milk but not in cow's milk. Although they may be beneficial, they are not required. 'These have been added to some formulas, but not to other formulas, so we want to take a look,' Abrams explained. Many parents have raised concerns over formula ingredients such as added sugars and seed oils, which are also being targeted by Kennedy as hazards in the wider food supply. Recent research suggests that added sugars such as glucose and corn syrup solids in infant formula may be linked to weight gain in children. Young said that most experts agree that lactose, the primary type of sugar found in breast milk, is preferred. Infant formulas in the U.S. do contain seed oils, Young said. But that's because there are a finite number of vegetable oils that provide the essential saturated and unsaturated fats that babies require. 'They need to provide the variety of fatty acids that you see in breast milk,' she said. What are the next steps? Done properly, the FDA's infant formula review would take 'at least a year,' Abrams said. And it will require broad input from multiple government agencies, formula manufacturers and consumers. 'No shortcuts are possible and no one review, white paper or even committee report will suffice to do it right,' he said. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store